Displaying 73 - 84 of 128
Metabolism, Alcohol & Toxicity
The contribution of metabolic co-morbidities and hepatic thyroid hormone dysregulation to the pathophysiology of NASH

The contribution of metabolic co-morbidities and hepatic thyroid hormone dysregulation to the pathophysiology of NASH

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Unmet needs in PBC: the patient perspective

Unmet needs in PBC: the patient perspective

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Welcome & objectives

Welcome & objectives

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Key considerations in the management of cirrhosis in PBC

Key considerations in the management of cirrhosis in PBC

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Q&A

Q&A

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Does our increasing knowledge of PBC pathogenesis affect early management?

Does our increasing knowledge of PBC pathogenesis affect early management?

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Enhancing clinical care strategies in PBC

Enhancing clinical care strategies in PBC

Webcasts
View
Viral Hepatitis
Overview of HBV antigens and relevance to functional cure

Overview of HBV antigens and relevance to functional cure

Webcasts
View
Viral Hepatitis
Discussion / Q&A

Discussion / Q&A

Webcasts
View
Cirrhosis & Complications
Modulating systemic inflammation: how does Albumin work?

Modulating systemic inflammation: how does Albumin work?

Webcasts
View
Cirrhosis & Complications
How do patients benefit from Albumin?

How do patients benefit from Albumin?

Webcasts
View
Cirrhosis & Complications
Summary and Conclusions “from a fluid to a  medicine”

Summary and Conclusions “from a fluid to a  medicine”

Webcasts
View
Displaying 73 - 84 of 128